Operating Lease, Right-of-Use Asset of Trevi Therapeutics, Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Trevi Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Trevi Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $741,000, a 24% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Trevi Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $741,000 -$232,000 -24% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $804,000 -$225,000 -22% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $865,000 -$219,000 -20% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $915,000 -$222,000 -20% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $973,000 -$217,000 -18% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $1,029,000 -$212,000 -17% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,084,000 -$208,000 -16% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,137,000 +$1,113,000 +4638% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $1,190,000 +$1,137,000 +2145% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,241,000 +$1,159,000 +1413% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,292,000 +$1,185,000 +1107% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $24,000 -$107,000 -82% 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $53,000 -$103,000 -66% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $82,000 -$99,000 -55% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $107,000 -$97,000 -48% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $131,000 -$96,000 -42% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $156,000 -$94,000 -38% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $181,000 -$90,000 -33% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $204,000 -$88,000 -30% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $227,000 -$85,000 -27% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $250,000 -$81,000 -24% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $271,000 -$79,000 -23% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $292,000 -$76,000 -21% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $312,000 -$67,000 -18% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $331,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $350,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $368,000 31 Mar 2019 10-Q 14 Jun 2019 2019 Q1
Q4 2018 $379,000 01 Jan 2019 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.